ארלוטיניב תרו 25 מג इसराइल - हिब्रू - Ministry of Health

ארלוטיניב תרו 25 מג

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 25 mg - erlotinib

סילריל פלוס इसराइल - हिब्रू - Ministry of Health

סילריל פלוס

unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

מוקוליט 375 קפסולות इसराइल - हिब्रू - Ministry of Health

מוקוליט 375 קפסולות

cts chemical industries ltd, israel - carbocisteine - קפסולות - carbocisteine 375 mg - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterised by excessive or viscous mucus.

מוקוליט 375 מג טבליות מציצה בטעם דבש-לימון इसराइल - हिब्रू - Ministry of Health

מוקוליט 375 מג טבליות מציצה בטעם דבש-לימון

cts chemical industries ltd, israel - carbocisteine - לכסניה - carbocisteine 375 mg - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterised by excessive or viscous mucus.

מוקוליט תמיסה למתן דרך הפה 250  מג 5 מל इसराइल - हिब्रू - Ministry of Health

מוקוליט תמיסה למתן דרך הפה 250 מג 5 מל

cts chemical industries ltd, israel - carbocisteine - תמיסה (פומי) - carbocisteine 250 mg / 5 ml - carbocisteine

ארלוטיניב טבע 100 מג इसराइल - हिब्रू - Ministry of Health

ארלוטיניב טבע 100 מג

teva israel ltd - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 100 mg - erlotinib

ארלוטיניב טבע 150 מג इसराइल - हिब्रू - Ministry of Health

ארלוטיניב טבע 150 מג

teva israel ltd - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

רוקסו 150 इसराइल - हिब्रू - Ministry of Health

רוקסו 150

unipharm ltd, israel - roxithromycin - טבליה - roxithromycin 150 mg - roxithromycin - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

דספרל 0.5 גרם इसराइल - हिब्रू - Ministry of Health

דספרל 0.5 גרם

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

רמיטנס 10 इसराइल - हिब्रू - Ministry of Health

רמיטנס 10

rafa laboratories ltd - ramipril - קפסולות - ramipril 10 mg - ramipril - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.